about
Fundamental aspects of solid dispersion technology for poorly soluble drugsThe Combined Use of Imaging Approaches to Assess Drug Release from Multicomponent Solid Dispersions.Mechanistic insights into acyclovir-polyethylene glycol 20000 binary dispersions.Enhancing the bioavailability of magnolol in rabbits using melting solid dispersion with polyvinylpyrrolidone.Molecular interaction studies of amorphous solid dispersions of the antimelanoma agent betulinic acidA study on the impact of hydroxypropyl methylcellulose on the viscosity of PEG melt suspensions using surface plots and principal component analysis.Enhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent process.New Perspectives for Fixed Dose Combinations of Poorly Water-Soluble Compounds: a Case Study with Ezetimibe and Lovastatin.Influence of Hydroxypropyl Methylcellulose on Metronidazole Crystallinity in Spray-Congealed Polyethylene Glycol Microparticles and Its Impact with Various Additives on Metronidazole Release.Drop Printing of Pharmaceuticals: Effect of Molecular Weight on PEG Coated-Naproxen/PEG3350 Solid Dispersions.Evaluation of Three Amorphous Drug Delivery Technologies to Improve the Oral Absorption of Flubendazole.Improved dissolution behavior of lipophilic drugs by solid dispersions: the production process as starting point for formulation considerations.Oral formulation strategies to improve solubility of poorly water-soluble drugs.Drug delivery strategies for poorly water-soluble drugs: the industrial perspective.Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs.Stability of amorphous pharmaceutical solids: crystal growth mechanisms and effect of polymer additivesSolid dispersions: a strategy for poorly aqueous soluble drugs and technology updates.Oral anticancer drugs: mechanisms of low bioavailability and strategies for improvement.Interactions between drugs and polymers influencing hot melt extrusion.Microenvironmental pH-modification to improve dissolution behavior and oral absorption for drugs with pH-dependent solubility.Hot-melt extrusion--basic principles and pharmaceutical applications.Refining stability and dissolution rate of amorphous drug formulations.Spray-congealed microparticles for drug delivery - an overview of factors influencing their production and characteristics.Challenges and Strategies in Thermal Processing of Amorphous Solid Dispersions: A ReviewHot Melt Extrusion: Development of an Amorphous Solid Dispersion for an Insoluble Drug from Mini-scale to Clinical Scale.Rational excipient selection for co-amorphous formulations.Stabilisation of an amorphous form of ROY through a predicted co-former interaction.Use of the Flory-Huggins theory to predict the solubility of nifedipine and sulfamethoxazole in the triblock, graft copolymer Soluplus.Preparation and characterisation of nevirapine oral nanosuspensions.Clinical pharmacokinetics of an amorphous solid dispersion tablet of elacridar.Griseofulvin/carrier blends: application of partial least squares (PLS) regression analysis for estimating the factors affecting the dissolution efficiency.Multivariate Quantification of the Solid State Phase Composition of Co-Amorphous Naproxen-Indomethacin.Preparation and characterization of celecoxib solid dispersions; comparison of poloxamer-188 and PVP-K30 as carriers.The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: impact on solubility.Preparation and characterization of celecoxib dispersions in soluplus(®): comparison of spray drying and conventional methods.Enhanced Bioavailability and Anticancer Effect of Curcumin-Loaded Electrospun Nanofiber: In Vitro and In Vivo Study.Atomic force microscopy-based screening of drug-excipient miscibility and stability of solid dispersions.Improving co-amorphous drug formulations by the addition of the highly water soluble amino Acid, proline.The influence of drug physical state on the dissolution enhancement of solid dispersions prepared via hot-melt extrusion: a case study using olanzapine.A novel surface-attached carvedilol solid dispersion with enhanced solubility and dissolution.
P2860
Q26822873-75DAD4AA-1895-4136-92B9-FCFAEEDEEE9BQ31125399-6252514F-6310-4F20-A3DA-8281D99CF987Q31156931-09ECAB62-E397-41B4-AD0D-8E01D8EFEF50Q34569875-5B47EFA3-221B-45A7-A99F-5DA7FA8D497BQ35209956-B1F28264-EF3B-40A1-B319-DF1C59A55050Q35209961-1B8140EE-FF37-4062-B41B-E343E3610B5FQ35592271-7D055D1C-1A71-41F4-A4B7-3E74D7A8136BQ35917803-18F5382F-81BB-4F4C-BCEE-6FBD8571705CQ36337318-0C561B79-B876-4139-8939-19841DAFAED0Q36748666-5FAE98EB-B577-41CF-8EDC-34A8887E86B6Q37183352-4B694247-23B1-4CAE-AE14-05A6547EA8EEQ37896655-BD0D88BC-410D-44AB-ADFB-CF8EEFC22680Q37910262-083FE1AA-BAF7-4A9F-BA46-BAC23DB45351Q37927093-411D552E-362B-4A34-8B45-CDE570BB240DQ37932560-66B02157-9A0C-4098-A9C8-F0B96B793E4FQ37995510-3DCB4480-BEF8-46B2-BC33-BBA06BDEBB44Q38050160-789BAA28-BAC4-4803-B758-725D02DC79D6Q38082728-885442C0-5746-4A42-A3FD-C03227BE7E4EQ38170190-A326E107-8942-43E6-AF54-B51DF340A6F9Q38182718-D1DCE360-873A-4137-AB8F-3E190CA609B6Q38187427-CB749E09-589C-475D-BCAA-F6CED8547DFCQ38206296-C293E13F-8C83-4E84-8876-CEF23CD98D1FQ38213463-5FDE9888-4C65-4B95-9FF9-72E59F1E6072Q38573948-F0F81D67-67BE-4AA1-A9A3-A3007AAB541FQ38619531-58AD8CAA-32E3-417F-BE15-033DD3F4386FQ38856865-C84B257E-A6EA-42AE-A93C-AF07BF2A22E2Q38876711-1E65342C-B328-4878-85DF-918AAC85CA17Q38972745-91BF7DDB-0A31-4653-A441-ACDBAF657238Q39141264-6D38CC27-9063-4718-869A-89D1D5743B81Q39172749-102D0D26-93D2-4C91-A807-7BBBB2715982Q39423564-A2F64946-81F7-42A1-AC04-E263C1F30CA0Q40375864-093DE650-6253-4AD7-AB49-15828F8FBE8EQ41132514-F2BD0D6E-042D-478B-974D-F881379CE1ACQ41335984-EA1F2BD9-6AD6-4782-A7D6-AF1676B4664EQ41870210-30062AA1-53FA-418D-A234-2369DAFD8C4EQ42066707-3BBD2593-6D55-49D6-A2C7-8A3E8D854166Q42628459-225E06EA-A7E5-467E-8940-6255B0157220Q42936240-C1018B73-5B3B-4365-B570-8D00B6953FB0Q43025396-CF42347A-0AD2-4946-8E38-4FFDFEC559F9Q44513984-D289D99D-B71C-4C6A-8109-93119AA2F08D
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Review: physical chemistry of solid dispersions.
@en
Review: physical chemistry of solid dispersions.
@nl
type
label
Review: physical chemistry of solid dispersions.
@en
Review: physical chemistry of solid dispersions.
@nl
prefLabel
Review: physical chemistry of solid dispersions.
@en
Review: physical chemistry of solid dispersions.
@nl
P2860
P356
P1476
Review: physical chemistry of solid dispersions.
@en
P2093
Guy Van den Mooter
Sandrien Janssens
P2860
P304
P356
10.1211/JPP.61.12.0001
P577
2009-12-01T00:00:00Z